Common Contracts
3 similar null contracts by Nexien Biopharma, Inc.
ContractNexien Biopharma, Inc. • February 11th, 2021 • Pharmaceutical preparations • Delaware
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO NEXIEN BIOPHARMA, INC.
CLASS E SHARE PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Nexien Biopharma, Inc. • September 28th, 2018 • Pharmaceutical preparations • Delaware
THIS CLASS E SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. Mountain Time on January 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (the “Warrant Shares”). The purchase price of one Warrant Share shall be equal to the Exercise Price, as defined in Section 1(b).
CLASS D UNIT PURCHASE WARRANT NEXIEN BIOPHARMA, INC.Nexien Biopharma, Inc. • September 28th, 2018 • Pharmaceutical preparations • Delaware
THIS CLASS D UNIT PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. Mountain Time on November 30, 2018 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NEXIEN BIOPHARMA, INC., a Delaware corporation (the “Company”), up to ______ Units each such Unit consisting of one share of Common Stock (the “Warrant Shares”) and one Class E Common Stock Purchase Warrant (the “Class E Warrants”), which such Class E Warrant shall have an exercise price equal to $2.00 per share and be exercisable through January 31, 2019. The purchase price of one Unit shall be equal to the Exercise Price, as defined in Section 1(b).
